Therapeutic Trials in Muscular Dystrophy
- 1 December 1977
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 34 (12) , 771-773
- https://doi.org/10.1001/archneur.1977.00500240059010
Abstract
From JAMA Neurology — Therapeutic Trials in Muscular Dystrophy — III. Studies of Microbial Proteinase Inhibitors in Murine DystrophyThis publication has 16 references indexed in Scilit:
- Therapeutic trials in muscular dystrophy: II. Ethylene and its derivativesAnnals of Neurology, 1977
- Postponement of symptoms of hereditary muscular dystrophy in chickens by 5-hydroxytryptamine antagonistsNature, 1976
- Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipainExperimental Neurology, 1976
- Direct evidence of importance of lysosomes in degradation of intracellular proteinsNature, 1975
- Glucagon treatment for muscular dystrophy in the mouseAmerican Journal of Physiology-Legacy Content, 1973
- Proteolytic Activity During Growth of Hypertrophic and Atrophic Muscles of Genetically Dystrophic ChickensExperimental Biology and Medicine, 1972
- Acid, Neutral and Alkaline Cathepsins in Normal and Diseased Human MuscleEnzyme, 1972
- Cathepsin Activity in Normal and Dystrophic Human MuscleEnzymologia Biologica Et Clinica, 1968
- Biochemistry of dystrophic muscle. 2. Some enzyme changes in dystrophic mouse muscleBiochemical Journal, 1963
- Enzyme Studies in Muscular Dystrophy. III. In Hereditary Muscular Dystrophy in Mice.Experimental Biology and Medicine, 1958